Your Notifications
All done, no notifications

What is Hepatocellular Carcinoma (HCC)?

Hepatocellular carcinoma is the most common type of liver cancer. It is an aggressive (fast-growing) cancer that most commonly affects persons with severe liver disease, such as cirrhosis. People with HCC are increasingly being diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), which can develop to cirrhosis.

What is the Importance of Timely Treatment?

  • Early treatment of Hepatocellular Carcinoma (HCC) is essential for improving patient outcomes and survival rates.
  • Early discovery enables more effective treatment choices, such as surgical resection, liver transplantation, or local therapy (e.g., ablation or embolisation), which may cure the cancer or considerably postpone its progression.
  • Delaying treatment can cause tumour growth, spread (metastasis), and poor liver function, making cancer more difficult to cure and decreasing the likelihood of a favourable outcome.
  • Early intervention also enhances quality of life by enabling more effective symptom management.

What are the Common Symptoms of Hepatocellular Carcinoma (HCC)?

Tumours may not present symptoms in their early stages. However, as HCC proceeds, you may notice the following:

  • Fullness or a knot under your right ribs (symptoms of an enlarged liver).
  • Fullness under your ribs on the left side (symptoms of an expanded spleen).
  • Yellowing of the eyes and skin (an indication of jaundice).
  • A distended stomach, as if it is overflowing with fluid.
  • Appetite loss or feeling full after eating a little meal.
  • Unexplained weight loss.
  • Nausea and vomiting.
  • Itching.

Causes and Risk Factors of Hepatocellular Carcinoma (HCC)

Causes

  • Hepatocellular carcinoma occurs when liver cells' DNA undergoes modifications (mutations).
  • A cell's DNA contains the instructions for every chemical process in your body. DNA mutations alter these instructions.
  • As a result, cells may grow out of control, eventually becoming a tumour—a mass of malignant cells.

Risk Factors

The following conditions enhance your risk of developing HCC:

  • Hepatitis B infection: Hepatitis B infection can cause HCC even in the absence of liver cirrhosis or before it develops.
  • Hepatitis C Infection: A viral infection that spreads through blood.
  • Metabolic dysfunction-associated steatotic liver disease (MASLD): It is a disorder that causes excessive fat to accumulate in the liver.
  • Alcohol use disorder: The liver has a tough time processing alcohol. Drinking too much of it can cause cirrhosis and liver cancer.

Connect with our advisor for a PRIORITY response

Latest Research and Technologies in the Treatment of Hepatocellular Carcinoma (HCC) in the United Arab Emirates

  • Hepatocellular carcinoma (HCC) imaging in the United Arab Emirates incorporates artificial intelligence to diagnose the disease earlier and more accurately by spotting minute patterns that human analysis frequently overlooks.
  • Ongoing research aims to enhance patient outcomes and optimise healthcare delivery for HCC by concentrating on AI-assisted tools for tailored medicine and treatment monitoring.

Hepatocellular Carcinoma (HCC) Prevention Tips

There are various ways to lower your chance of having HCC. You can do:

  • To lower your risk of developing cirrhosis, avoid drinking alcohol.
  • Maintain a healthy weight.
  • Vaccinate against hepatitis B.
  • You can lower your risk of contracting hepatitis B by getting the vaccine.
  • Take steps to prevent hepatitis C.
  • Do not use intravenous drugs,
  • When getting a piercing or tattoo, look for safe and clean shops.
  • Seek treatment for hepatitis B or C infections.

Treatment options for Hepatocellular Carcinoma (HCC)

Surgery: The surgical treatments for HCC are hepatectomy (removal of the diseased section of the liver) or liver transplantation.

{liver-transplant}

Ablation therapy: This involves the use of a specialised needle to burn malignancies. The needle can direct highly hot energy (microwaves or radiofrequency waves) or extremely cold.

Embolisation: This is the process of implanting a material directly into the arteries that supply the tumour, blocking blood flow.

Radiation therapy: Providers may recommend radiation therapy to treat tiny cancers that cannot be removed surgically or destroyed through ablation.

Immunotherapy: Immunotherapy drugs are also used to treat advanced HCC. They help your immune system recognise and combat cancer cells.

{immunotherapy}

Targeted therapy: These medications treat advanced HCC. This medication inhibits the signal that tells cancer cells to continue growing.


Cost Start From USD 5500 - USD 54000Explore Options

  • Blood tests: Your provider may check your blood for indicators of HCC, such as elevated alpha-fetoprotein (AFP) levels. Elevated AFP levels may indicate HCC or a disease that can develop into HCC, such as hepatitis infection or liver cirrhosis.
  • Imaging scans: Imaging treatments such as an ultrasound, computed tomography (CT) scan, magnetic resonance imaging (MRI), or angiography can detect cancers (or indicators of a tumour) within your liver.
  • Liver biopsy: Your doctor may do a liver biopsy to look for cancer cells. If your bloodwork and imaging scans do not provide enough information to make a diagnosis, you may need this test.

Hepatocellular Carcinoma (HCC) rehabilitation treatments aim to increase quality of life, accelerate physical recovery, and minimise therapeutic side effects. Here are the main rehabilitation alternatives for HCC patients:

  • Physical Rehabilitation: After liver surgery or transplant, patients may receive physical therapy to restore strength, increase flexibility, and minimise fatigue. A personalised workout regimen might help you improve your overall fitness and stamina.
  • Mobility assistance: Patients with limited movement due to treatment side effects may benefit from exercises to enhance balance and coordination.
  • Psychosocial support: Therapy or joining a support group can help cancer patients deal with the emotional and mental challenges of their treatment.

MediGence can assist and guide you in selecting the best physician and medical facility for your care.

Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.

Treatment regimens are adapted to the patient's specific cancer stage and location.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Hepatocellular Carcinoma (HCC) in United Arab Emirates

Thumbay University Hospital, Ajman: Top Doctors, and Reviews
Thumbay University Hospital, Ajman

Ajman, United Arab Emirates

Thumbay University Hospital, Ajman located in Ajman, United Arab Emirates is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

  • The hospital has a 250 bed capacity.
  • Excellent quality of healthcare facilities and services at par with developed countries.
  • Multilingual and multinational healthcare professionals working in the Thumbay Hospital Ajman (belonging to 20 nations and fluent in 50 plus languages).
  • Equipped with the newest facilities to ensure highest standards of healthcare delivery to patients at economical costs.
  • Dedicated, compassionate and highly educated healthcare professionals work in Thumbay Hospital Ajman.
  • Well developed diagnostic facilities are also available.
  • A 24/7 functioning emergency care department and advanced facilities in Radiology.
  • There is presence of an ultramodern Catheterization Lab (Cath Lab) and Electrosurgery Cryotherapy in dermatology, Interlocking intramedullary nailing.
  • Also available under dental departments Panoramic, digital intra-oral X-rays, Cephalogram are present.
  • Some of the important specialties in Thumbay Hospital Ajman are:
    • Ear, nose, and throat
    • Cardiovascular
    • Bariatric surgery
    • General surgery
    • Urology
    • Nephrology

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose the United Arab Emirates for Hepatocellular Carcinoma (HCC) Treatment?

Here are some of the reasons for choosing United Arab Emirates:

  • World-Class Medical Expertise: The United Arab Emirates has qualified oncologists and hepatologists who specialise in hepatocellular carcinoma treatment.
  • Advanced Technologies: Treatment options include radiofrequency ablation (RFA), liver transplantation, and targeted medicines that use recent medical advances.
  • Affordable Care: Compared to other nations, the United Arab Emirates provides high-quality HCC treatments at a lower cost.
  • Comprehensive Patient Support: International patients receive seamless services, such as language support and specialised care, to ensure a smooth treatment experience.
  • Accredited Hospitals: The United Arab Emirates's hospitals are internationally recognised, guaranteeing that patients receive high-quality care and treatment.

Frequently Asked Questions

In the United Arab Emirates, liver transplantation is a viable therapy option for hepatocellular carcinoma (HCC), particularly for patients with cirrhosis, liver tumours, and early-stage malignancy. Numerous respectable transplant centres in the United Arab Emirates perform successful liver transplants and offer complete care.

In the United Arab Emirates, hepatocellular carcinoma (HCC) is effectively treated, especially when caught early. UAE hospitals use cutting-edge therapy to achieve exceptional patient outcomes.

The nation's sophisticated equipment, highly skilled specialists, and comprehensive treatment programs result in higher survival rates and improved quality of life for patients receiving treatment for HCC.

In the United Arab Emirates, hepatocellular carcinoma (HCC) is effectively treated, especially when caught early. UAE hospitals use cutting-edge therapy to achieve exceptional patient outcomes.

The nation's sophisticated equipment, highly skilled specialists, and comprehensive treatment programs result in higher survival rates and improved quality of life for patients receiving treatment for HCC.

Yes, lifestyle changes include:

  • Consuming a nutritious diet rich in fruits and vegetables.
  • Exercise regularly to maintain a healthy weight.
  • Avoid alcohol and smoking.
  • Managing chronic liver illnesses such as hepatitis or fatty liver can help avoid or better manage HCC.

Hepatocellular carcinoma (HCC) is less common in the United Arab Emirates than in East Asia and Sub-Saharan Africa. The incidence rate is very low. One of the main risk factors is the prevalence of chronic hepatitis B and C virus infections in the United Arab Emirates. Reducing the prevalence of HCC in the United Arab Emirates requires constant monitoring and management of these risk factors.

According to developments in treatments like liver transplants, surgery, and customised medications, many patients can maintain a high quality of life. However, the impact of the condition differs according to the stage of the malignancy and available treatments.